CASE DISCUSSION
Recurrent IVF Failure: Diagnostic and Management Approach
Presented by Dr. Richika SahayViews
13,327
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Recurrent IVF Failure: Diagnostic and Management Approach focuses on understanding the complex causes behind repeated unsuccessful in vitro fertilization (IVF) cycles. It highlights key diagnostic evaluations, including uterine assessment, embryo quality, genetic testing, immunological factors, and...
Case Summary
- Recurrent Implantation Failure (RIF) is defined as the failure to achieve clinical pregnancy after multiple embryo transfers (3 cycles with good embryos, >5 blastocysts, or 4 good quality embryos in <40-year-old women). The European Society of Human Reproduction and Embryology (ESHRE) 2023 defines RIF as a lower-than-expected implantation probability despite transferring good quality, euploid blastocysts.
Speaker Profile
Dr. Richika Sahay
Alumni- MGM Medical CollegeDr. Richika Sahay is a leading fertility specialist and Gynec-Laparoscopic Surgeon with extensive experience in reproductive medicine and women’s health.
She serves as the Director at India IVF Clinic and is also associated with Fortis Hospital as Head Fertility Specialist and Gynec-Laparoscopic Surgeon.
Her expertise includes infertility management, IVF treatments, reproductive endocrinology, and minimally invasive gynecological surgeries.
She is dedicated to providing personalized, evidence-based fertility care focused on improving reproductive outcomes for couples.
Through her clinical practice and leadership roles, she continues to contribute to advancements in assisted reproductive technologies and women’s healthcare.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.